FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/02/2022
Back to search
Official data from USPTO
PLECOID
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PLECOID
ST13
US500000079306239Class
1, 5, 44
Filing
79306239
Registration
6733742
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
10/02/2022
Trademark type
Word
Nice classes
1, 5, 44
Filing date
01/04/2021
Registration date
05/24/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/24/2022
Last transaction
05/24/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
NL
Examiner
OSGOOD, KRYSTINA
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Pleco Therapeutics B.V.
Representatives
Thomas D. Bratschun Adsero IP
Technical classification
Nice Classes
Class 1Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in sciencescientific research and for laboratory use; analytical and diagnostic reagents for in vitro use for scientific and research purposes
Class 5
Pharmaceuticals for the treatment of viral infections; pharmaceuticals for the treatment of cardiovascular disorders and conditions; pharmaceuticals for the treatment of neurological diseases and disorders; pharmaceuticals for the treatment of respiratory disorders and conditions; pharmaceuticals for the treatment of fungal diseases and disorders; pharmaceuticals for the treatment of liver disease; pharmaceuticals for the treatment of HIV/AIDS and hepatitis; pharmaceuticals for the treatment of inflammatory diseases and disorders; pharmaceuticals for the treatment of cancer; pharmaceutical preparations for immunotherapyincluding t cell therapy
Class 44
Providing health and medical information about medical disorders and their diagnosisprevention and treatment; counselling and charitable services for patientsproviding medical information and assistance with respect to obtaining prescription medications; medical consultationproviding advice to healthcare professionals regarding medical disorders and their diagnosisprevention and treatment; providing medical information; providing medical information regarding treatmentpreventiondiagnosis of medical conditions; medical information and advisory services relating to pharmaceuticalsdiseases and medical conditions and treatmentincluding such services provided on-line from a computer network or the Internet
Publications
History of USPTO decisions and trademark events.
26 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/14/2022
FIMP
FINAL DISPOSITION PROCESSED
09/14/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/24/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/24/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
05/24/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/08/2022
PUBO
PUBLISHED FOR OPPOSITION
03/08/2022
GPNX
NOTIFICATION PROCESSED BY IB
03/07/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/16/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/16/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/16/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/02/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/21/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/20/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/20/2022
RFNT
REFUSAL PROCESSED BY IB
08/08/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/22/2021
RFRR
REFUSAL PROCESSED BY MPU
07/22/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/14/2021
CNRT
NON-FINAL ACTION WRITTEN
07/13/2021
DOCK
ASSIGNED TO EXAMINER
07/13/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
05/21/2021
MAFR
APPLICATION FILING RECEIPT MAILED
03/16/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/12/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/11/2021
Continuous trademark protection
Get notified about every new filing that threatens PLECOID or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.